Tetracycline
/
|
Salmonella None
|
See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
Small markets |
196 |
|
260 |
Large markets |
173 |
|
248 |
|
Ampicillin
/
|
Salmonella None
|
See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
Small markets |
169 |
|
260 |
Large markets |
154 |
|
248 |
|
Nalidixic Acid
/
|
Salmonella None
|
See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
Small markets |
158 |
|
260 |
Large markets |
154 |
|
248 |
|
Sulfamethoxazole And Trimethoprim
/
|
Salmonella None
|
See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
Small markets |
162 |
|
260 |
Large markets |
139 |
|
248 |
|
Amoxicillin And Beta-Lactamase Inhibitor
/
|
Salmonella None
|
See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
Small markets |
126 |
|
260 |
Large markets |
116 |
|
248 |
|
Chloramphenicol
/
|
Salmonella None
|
See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
Small markets |
127 |
|
260 |
Large markets |
100 |
|
248 |
|
Kanamycin
/
|
Salmonella None
|
See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
Small markets |
111 |
|
260 |
Large markets |
107 |
|
248 |
|
Streptomycin
/
|
Salmonella None
|
See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
Small markets |
98 |
|
260 |
Large markets |
101 |
|
248 |
|
Gentamicin
/
|
Salmonella None
|
See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
Small markets |
97 |
|
260 |
Large markets |
90 |
|
248 |
|
Ceftiofur
/
|
Salmonella None
|
See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
Small markets |
71 |
|
260 |
Large markets |
69 |
|
248 |
|
Amikacin
/
|
Salmonella None
|
See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
Small markets |
67 |
|
260 |
Large markets |
69 |
|
248 |
|
Ceftriaxone
/
|
Salmonella None
|
See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
Small markets |
58 |
|
260 |
Large markets |
65 |
|
248 |
|
Ciprofloxacin
/
|
Salmonella None
|
See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
Small markets |
55 |
|
260 |
Large markets |
62 |
|
248 |
|
Cefoxitin
/
|
Salmonella None
|
See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
Small markets |
52 |
|
260 |
Large markets |
49 |
|
248 |
|